Skip to content
Trial Eligibility
Menu

Prostate Cancer Clinical Trials near New Haven, CT

56 studies for Prostate Cancer are recruiting at 102 sites within 50 miles of New Haven, Connecticut, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Prostate Cancer trials in the US or all trials near New Haven.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Prostate Cancer studies enrolling near New Haven

Showing the 50 nearest of 56 studies.
  1. Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

    NCT05806515

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Smilow Cancer Center/Yale-New Haven Hospital (New Haven, CT); Yale University (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    14 sites within 50 mi
  2. Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

    NCT03678025

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Yale University (New Haven, CT); Veterans Affairs Connecticut Healthcare System-West Haven Campus (West Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  3. Study of PF-07248144 in Advanced or Metastatic Solid Tumors

    NCT04606446

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Smilow Cancer Hospital Phase 1 Unit (New Haven, CT); Smilow Cancer Hospital at Yale - New Haven (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  4. A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

    NCT06457919

    • Phase 1/2
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Yale University (Data Collection Only) (New Haven, CT); Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) (Commack, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  5. A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

    NCT06925737

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Yale-New Haven Hospital-Yale Cancer Center ( Site 0050) (New Haven, CT); Veterans Affairs Connecticut Healthcare System ( Site 0062) (West Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  6. International Registry for Men With Advanced Prostate Cancer (IRONMAN)

    NCT03151629

    • Observational
    • Ages 21 years and older
    • Sex: Male

    Nearest site: Yale University (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  7. A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

    NCT03972657

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale University Hospital (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  8. Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

    NCT04221542

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Yale New Haven Hospital (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  9. The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

    NCT04585750

    • Phase 1/2
    • Ages 12 years and older
    • Sex: All

    Nearest site: Yale Cancer Center (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  10. A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer

    NCT05125016

    • Phase 1/2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Yale University Hospital (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  11. Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

    NCT05176483

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Exelixis Clinical Site #62 (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  12. Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

    NCT05519449

    • Phase 1
    • Ages 18 to 100 years
    • Sex: Male

    Nearest site: Yale New Haven Hospital (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  13. A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

    NCT05652686

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale University Cancer Center (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

    NCT05800665

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Yale Cancer Center (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. FOG-001 in Locally Advanced or Metastatic Solid Tumors

    NCT05919264

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale University School of Medicine (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

    NCT05983432

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale University, Yale Cancer Center (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC

    NCT06100705

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale Cancer Center (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. The SUGAR Study; SBRT and Relugolix) for Prostate Cancer

    NCT06111781

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Yale Cancer Center (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

    NCT06136624

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale-New Haven Hospital-Yale Cancer Center ( Site 0064) (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

    NCT06136650

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale-New Haven Hospital-Yale Cancer Center ( Site 0064) (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

    NCT06172478

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale Cancer Center (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

    NCT06395519

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale University, Yale Cancer Center (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies

    NCT06458712

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale Cancer Center - Yale New Haven Hospital (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  24. Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

    NCT06800313

    • Phase 1/2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Yale University (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

    NCT06842498

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: New Haven Hospital - Yale Cancer Center (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer

    NCT06990880

    • Phase 1/2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: GSK Investigational Site (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  27. Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

    NCT07080242

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale Cancer Center (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  28. High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

    NCT05011383

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: VA Connecticut Healthcare System West Haven Campus, West Haven, CT (West Haven, CT)

    Distance to nearest recruiting site
    ~3 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  29. Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

    NCT06592924

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Veterans Affairs Connecticut Healthcare System-West Haven Campus (West Haven, CT)

    Distance to nearest recruiting site
    ~3 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  30. A Single-arm, Multicenter Prospective Study to Evaluate the Diagnostic Performance of PROSTest in Men With PSA ≥ 3ng/ml Using Biopsy as the Sole Ground Truth

    NCT07454603

    • Observational
    • Ages 45 to 80 years
    • Sex: Male

    Nearest site: Wren Laboratories (Branford, CT)

    Distance to nearest recruiting site
    ~6 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  31. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    NCT03452774

    • Observational
    • Ages Any age
    • Sex: All

    Nearest sites: Massive Bio SYNERGY-AI site (Norwalk, CT); Massive Bio SYNERGY-AI site (Hartford, CT)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  32. Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

    NCT05946213

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Stony Brook University Medical Center (Stony Brook, NY); Northwell Health Cancer Institute at Huntington (Greenlawn, NY)

    Distance to nearest recruiting site
    ~29 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  33. Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

    NCT04423211

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Stony Brook University Medical Center (Stony Brook, NY); Northwell Health Imbert Cancer Center (Bay Shore, NY)

    Distance to nearest recruiting site
    ~29 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  34. Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

    NCT06931340

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Stony Brook University Medical Center (Stony Brook, NY); Memorial Sloan Kettering Commack (Commack, NY)

    Distance to nearest recruiting site
    ~29 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  35. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    NCT05334069

    • Observational
    • Ages 40 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Stony Brook University Medical Center (Stony Brook, NY)

    Distance to nearest recruiting site
    ~29 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  36. Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

    NCT05803941

    • Phase 4
    • Ages 18 to 100 years
    • Sex: Male

    Nearest site: Hartford Hospital (Hartford, CT)

    Distance to nearest recruiting site
    ~34 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  37. Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

    NCT06780670

    • Phase 2/3
    • Ages 18 to 100 years
    • Sex: Male

    Nearest site: Hartford Hospital (Hartford, CT)

    Distance to nearest recruiting site
    ~34 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  38. A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

    NCT07164443

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Hartford Hospital (Hartford, CT)

    Distance to nearest recruiting site
    ~34 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  39. A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

    NCT07213674

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Hartford HealthCare Cancer Institute at Hartford Hospital (Hartford, CT)

    Distance to nearest recruiting site
    ~34 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  40. Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

    NCT06632977

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Stamford Hospital/Bennett Cancer Center (Stamford, CT)

    Distance to nearest recruiting site
    ~36 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  41. [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate or Salivary Gland Cancer

    NCT00588185

    • Interventional
    • Ages Any age
    • Sex: Male

    Nearest sites: Memorial Sloan Kettering Commack (Consent only) (Commack, NY); Memorial Sloan Kettering Westchester (Consent only) (Harrison, NY)

    Distance to nearest recruiting site
    ~37 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  42. Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

    NCT03866382

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Memorial Sloan Kettering Commack (Commack, NY); Memorial Sloan Kettering Westchester (Harrison, NY)

    Distance to nearest recruiting site
    ~37 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  43. A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer

    NCT06347705

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity) (Commack, NY); Memorial Sloan Kettering Westchester (Limited Protocol Activities) (Harrison, NY)

    Distance to nearest recruiting site
    ~37 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  44. MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial

    NCT06954337

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities) (Commack, NY); Memorial Sloan Kettering Westchester (All Protocol Activities) (Harrison, NY)

    Distance to nearest recruiting site
    ~37 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  45. A Study of Changes to Prostate Procedures

    NCT06986083

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Memorial Sloan Kettering Suffolk-Commack (Consent only) (Commack, NY); Memorial Sloan Kettering Westchester (Consent Only) (Harrison, NY)

    Distance to nearest recruiting site
    ~37 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  46. This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

    NCT07028853

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: MSK Commack (Commack, NY); MSKCC-Westchester (500 Westchester Ave.) (Harrison, NY)

    Distance to nearest recruiting site
    ~37 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  47. A Study of Tarlatamab for People With Prostate Cancer

    NCT07111507

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) (Commack, NY); Memorial Sloan Kettering Westchester (Limited Protocol Activities) (Harrison, NY)

    Distance to nearest recruiting site
    ~37 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  48. Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

    NCT07200830

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Memorial Sloan Kettering Commack (Commack, NY); Memorial Sloan Kettering Westchester (Harrison, NY)

    Distance to nearest recruiting site
    ~37 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  49. Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer

    NCT07548164

    • Phase 3
    • Ages Any age
    • Sex: Male

    Nearest sites: Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) (Commack, NY); Memorial Sloan Kettering at Westchester (Limited Protocol Activities) (Harrison, NY)

    Distance to nearest recruiting site
    ~37 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  50. A Study of Lower Dose Radiation Therapy for People With Prostate Cancer

    NCT07635238

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Memorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities) (Commack, NY); Memorial Sloan Kettering at Westchester (Limited Protocol Activities) (Harrison, NY)

    Distance to nearest recruiting site
    ~37 mi (city-level)
    Recruiting sites
    2 sites within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Prostate Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.